NYSE:NHWK NightHawk Biosciences (NHWK) Stock Price, News & Analysis $0.44 -0.05 (-10.20%) (As of 12/29/2023 ET) Add Compare Share Share Today's Range$0.44▼$0.4850-Day Range$0.26▼$0.5052-Week Range$0.26▼$1.29Volume192,627 shsAverage Volume307,237 shsMarket Capitalization$11.48 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media About NightHawk Biosciences Stock (NYSE:NHWK)NightHawk Biosciences, Inc., an integrated biopharmaceutical company, develops, manufactures, and commercializes medical countermeasures that combat unmet and emerging biothreats. The company develops ANTHIM (obiltoxaximab), a monoclonal antibody antitoxin for the treatment of inhalational anthrax. The company was formerly known as Heat Biologics, Inc. and changed its name to NightHawk Biosciences, Inc. in May 2022. NightHawk Biosciences, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.Read More NHWK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NHWK Stock News HeadlinesDecember 21, 2023 | finance.yahoo.comNightHawk Biosciences Announces Completion of Demonstration Run for a Top-Tier NIH and DTRA Funded Research UniversityDecember 19, 2023 | msn.comNightHawk Biosciences files for $200M mixed securities shelfDecember 31, 2023 | Behind the Markets (Ad)FINAL OFFER: $9 for a FULL YEAR of stock picksWe're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $9. That's less than a cup of coffee! And what do you get for that $9?December 18, 2023 | finance.yahoo.comNightHawk Biosciences Announces Major Milestone with Completion of Manufacturing Run for a Premier U.S.-Based Biopharmaceutical CompanyDecember 12, 2023 | finance.yahoo.comNightHawk Biosciences Announces Strategic Shift into a Pure-Play Large Molecule Biomanufacturing CDMO to Capitalize on Rapid Growth in Sales Pipeline along with Divestiture of Non-Core AssetsDecember 3, 2023 | morningstar.comNightHawk Biosciences Inc NHWKNovember 29, 2023 | bizjournals.comMorrisville public company looks to divest subsidiary after CEO tried to buy itNovember 20, 2023 | msn.comNightHawk Biosciences reports Q3 resultsDecember 31, 2023 | Behind the Markets (Ad)FINAL OFFER: $9 for a FULL YEAR of stock picksWe're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $9. That's less than a cup of coffee! And what do you get for that $9?November 20, 2023 | finance.yahoo.comNightHawk Biosciences Provides Q3 2023 Business UpdateOctober 9, 2023 | finance.yahoo.comNHWK: 2Q:23 ResultsAugust 24, 2023 | finance.yahoo.comMorrisville CEO pitches to buy his company's subsidiary for $45M+August 24, 2023 | finance.yahoo.comMorrisville CEO wants to acquire his company's subsidiary for $45M+August 21, 2023 | marketwatch.comNightHawk Biosciences CEO Offers to Buy Its Elusys UnitAugust 15, 2023 | seekingalpha.comNightHawk Biosciences GAAP EPS of -$0.53 misses by $0.08, revenue of $0.7M misses by $0.2MAugust 14, 2023 | finance.yahoo.comNightHawk Biosciences Provides Q2 2023 Business UpdateMay 19, 2023 | finance.yahoo.comNHWK: First Scorpius RevenuesMay 15, 2023 | msn.comNightHawk Biosciences GAAP EPS of -$0.49May 15, 2023 | finance.yahoo.comNightHawk Biosciences Provides Q1 2023 Business UpdateMay 2, 2023 | msn.comBrookline Capital Downgrades NightHawk Biosciences (NHWK)April 28, 2023 | benzinga.comNightHawk Biosciences Stock (AMEX:NHWK), DividendsApril 11, 2023 | finance.yahoo.comNHWK: ANTHIM Sales Boost RevenuesApril 4, 2023 | msn.comMaxim Group Downgrades Nighthawk Biosciences (NHWK)April 3, 2023 | msn.comNightHawk Biosciences's Return On Capital Employed InsightsMarch 31, 2023 | finance.yahoo.comNightHawk Biosciences Provides 2022 Year End Business UpdateMarch 23, 2023 | ca.finance.yahoo.comNightHawk Biosciences, Inc. (NHWK)December 12, 2022 | finance.yahoo.comNHWK: Shifting Focus to BiomanufacturingSee More Headlines Receive NHWK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NightHawk Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/20/2023Today12/31/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNYSE:NHWK CUSIPN/A CIK1476963 Webwww.nighthawkbio.com Phone919-240-7133FaxN/AEmployees77Year Founded2008Profitability EPS (Most Recent Fiscal Year)($1.99) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-43,440,000.00 Net Margins-2,333.27% Pretax Margin-2,546.97% Return on Equity-91.62% Return on Assets-56.48% Debt Debt-to-Equity Ratio0.27 Current Ratio0.99 Quick Ratio0.99 Sales & Book Value Annual Sales$6.38 million Price / Sales1.80 Cash FlowN/A Price / Cash FlowN/A Book Value$2.82 per share Price / Book0.16Miscellaneous Outstanding Shares26,080,000Free Float21,935,000Market Cap$11.48 million OptionableNot Optionable Beta0.45 Social Links Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Jeffrey Alan Wolf J.D. (Age 60)Founder, Chairman of the Board, CEO & President Comp: $842.6kMr. William L. Ostrander (Age 55)CFO & Secretary Comp: $476.24kDr. Ryan D. Michalek Ph.D.Senior Vice President of Operations & Strategic DevelopmentDr. Justin Stebbing FRCPFRCPath, M.A., M.D., Ph.D., Chief Medical Advisor and Member of Scientific & Clinical Advisory BoardColonel George E. Peoples Jr.F.A.C.S., M.D., Chief Medical AdvisorKey CompetitorsAraviveNASDAQ:ARAVABVC BioPharmaNASDAQ:ABVCGeoVax LabsNASDAQ:GOVXTonix PharmaceuticalsNASDAQ:TNXPCyclerion TherapeuticsNASDAQ:CYCNView All Competitors NHWK Stock Analysis - Frequently Asked Questions Should I buy or sell NightHawk Biosciences stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for NightHawk Biosciences in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NHWK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHWK, but not buy additional shares or sell existing shares. View NHWK analyst ratings or view top-rated stocks. How have NHWK shares performed in 2023? NightHawk Biosciences' stock was trading at $0.8051 on January 1st, 2023. Since then, NHWK shares have decreased by 45.3% and is now trading at $0.4403. View the best growth stocks for 2023 here. How were NightHawk Biosciences' earnings last quarter? NightHawk Biosciences, Inc. (NYSE:NHWK) announced its quarterly earnings results on Monday, November, 20th. The biopharmaceutical company reported ($0.38) EPS for the quarter, missing the consensus estimate of ($0.35) by $0.03. The biopharmaceutical company had revenue of $0.72 million for the quarter, compared to analyst estimates of $1.60 million. NightHawk Biosciences had a negative net margin of 2,333.27% and a negative trailing twelve-month return on equity of 91.62%. When did NightHawk Biosciences' stock split? NightHawk Biosciences shares reverse split on the morning of Friday, December 11th 2020. The 1-7 reverse split was announced on Thursday, December 10th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 11th 2020. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split. How do I buy shares of NightHawk Biosciences? Shares of NHWK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:NHWK) was last updated on 12/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NightHawk Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.